Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News AHA 2018

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

Michael O'Riordan

November 11, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

Patients With Chest Pain Less Likely to Die After Discharge From High-Volume EDs

L.A. McKeown

October 26, 2018

News Daily News

Post-MI Beta-blocker Use Dropped During Metoprolol ER Shortage, but Outcomes Unaffected

Todd Neale

October 15, 2018

News Daily News

Silent Infarcts Have Similar Mortality Over 10 Years as Clinically Recognized MI

Yael L. Maxwell

October 10, 2018

News Daily News

Takotsubo Syndrome Linked to Heart Failure Admissions and Mortality Risk in Nationwide Study

Yael L. Maxwell

October 05, 2018

News Daily News

Out-of-Hospital Cardiac Arrest Protocol With Cooling, Angiography Gets ‘Extraordinary’ Results

Caitlin E. Cox

September 19, 2018

News Conference News ESC 2018

Largest-Ever SCAD Analysis Links Peripartum Status to Poor Outcomes

Todd Neale

August 30, 2018

News Conference News ESC 2018

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

Shelley Wood

August 29, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Daily News

Women With Acute MI More Likely to Survive If Treated by Female Physicians

Shelley Wood

August 08, 2018

News Daily News

Marijuana and Cocaine Use in Young MI Patients Linked to Mortality Risks

L.A. McKeown

June 04, 2018

News Conference News EuroPCR 2018

Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel

Yael L. Maxwell

May 30, 2018

News Conference News SCAI 2018

Culprit Vessel-Only Interventions in Cardiogenic Shock, Acute MI Get Boost in Registry Analysis

Shelley Wood

April 26, 2018

News Daily News

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

Michael O'Riordan

April 25, 2018

News Daily News

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Michael O'Riordan

April 24, 2018

News Daily News

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

L.A. McKeown

March 29, 2018

News Daily News

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Caitlin E. Cox

March 26, 2018

News Conference News ACC 2018

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Yael L. Maxwell

March 19, 2018

Advertisement

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Patients With Chest Pain Less Likely to Die After Discharge From High-Volume EDs

Post-MI Beta-blocker Use Dropped During Metoprolol ER Shortage, but Outcomes Unaffected

Silent Infarcts Have Similar Mortality Over 10 Years as Clinically Recognized MI

Takotsubo Syndrome Linked to Heart Failure Admissions and Mortality Risk in Nationwide Study

Out-of-Hospital Cardiac Arrest Protocol With Cooling, Angiography Gets ‘Extraordinary’ Results

Largest-Ever SCAD Analysis Links Peripartum Status to Poor Outcomes

High-STEACS: Sensitive Troponin Tests Rule Out MI, but Have No Impact on Hard Events

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Women With Acute MI More Likely to Survive If Treated by Female Physicians

Marijuana and Cocaine Use in Young MI Patients Linked to Mortality Risks

Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel

Culprit Vessel-Only Interventions in Cardiogenic Shock, Acute MI Get Boost in Registry Analysis

FDA Advisory Panel Says Celecoxib Is as Safe for Heart as Ibuprofen and Naproxen

FDA Advisors Take Fresh Look at Celecoxib Safety as PRECISION Aspirin Analysis Unveiled

Videos Boost Oral and Written Explanations to Help Patients Understand PCI

Varenicline Boosts Long-term Quit Rate in Post-ACS Smokers: EVITA

Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content